Nicholas A. Saccomano
CSO, ARRAY BIOPHARMA INC.
Companies
- OnKure Therapeutics, Inc.Board member Oct 8, 2024 to now1
- OnKure Therapeutics, Inc.Chief executive officer Oct 8, 2024 to now1
- OnKure Therapeutics, Inc.President Oct 8, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- OnKure Therapeutics, Inc. OKUR11,160 shares2$23.8K at $2.13Sep 21, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 21, 2026Sold 87 shares at $2.97 of OnKure Therapeutics, Inc.2
- Jun 22, 2026Sold 86 shares at $4.40 of OnKure Therapeutics, Inc.3
- Mar 23, 2026Sold 86 shares at $4.16 of OnKure Therapeutics, Inc.4
- Dec 22, 2025Sold 87 shares at $2.97 of OnKure Therapeutics, Inc.5
- Sep 22, 2025Sold 88 shares at $2.62 of OnKure Therapeutics, Inc.6
- Jun 23, 2025Sold 88 shares at $2.38 of OnKure Therapeutics, Inc.7
- Apr 7, 2025Sold 516 shares at $2.67 of OnKure Therapeutics, Inc.8
- Apr 4, 2025Sold 358 shares at $3.33 of OnKure Therapeutics, Inc.8
- Oct 4, 2024Granted 4,556 shares of OnKure Therapeutics, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jun 24, 2026
- 4SEC EDGARForm 4 filed Mar 24, 2026
- 5SEC EDGARForm 4 filed Dec 23, 2025
- 6SEC EDGARForm 4 filed Sep 24, 2025
- 7SEC EDGARForm 4 filed Jun 25, 2025
- 8SEC EDGARForm 4 filed Apr 8, 2025
- 9SEC EDGARForm 4 filed Oct 8, 2024